Results 141 to 150 of about 87,373,768 (197)

Three trajectories of implementation of medications for opioid use disorder in primary care. [PDF]

Addict Sci Clin Pract
Kepner W, Vest N, Risner E, Cheng H, Hurley B, Snyder H, McGovern M.   +6 more
europepmc   +1 more source

The Financial Sustainability of Programs to Initiate Medications for Opioid Use Disorder in Emergency Department Settings. [PDF]

Acad Emerg Med
Hodgkin D, Thomas CP, Davis MT, Wicks JJ, Greenfield SF, Meisel ZF, Horgan CM.   +6 more
europepmc   +1 more source

Access to medications for opioid use disorder among primary care patients with homeless experience in the Department of Veterans Affairs. [PDF]

Drug Alcohol Depend
Jones AL, Li H, Baylis JD, Huebler S, Suo Y, Zhang Y, Gelberg L, Zickmund S, Greene TH, Kertesz SG, Gordon AJ.   +10 more
europepmc   +1 more source

Circulating plasma protein biomarkers associated with risk of negative clinical outcomes in virally suppressed people with HIV receiving medications for opioid use disorder. [PDF]

Front Mol Biosci
Azzoni L, Zhang L, Zhu K, Fair M, Hiserodt E, Mounzer K, Wallin JJ, Montaner LJ, Cai Y.   +8 more
europepmc   +1 more source

Medicaid prescription cap policies and exemptions for medications for opioid use disorder: A process and content analysis. [PDF]

Health Aff Sch
Hughto JMW, Vento S, Pletta DR, Noh M, Shireman TI, Santostefano CM, Hughes LD, Peterson L, Seymour E, Stettenbauer EG, Dow PM.   +10 more
europepmc   +1 more source

A Virtual Reality Intervention to Promote Uptake of Medications for Opioid Use Disorder in the Emergency Department Following Opioid-Involved Overdose Based on Input From People With Lived Experience: Development Study. [PDF]

JMIR XR Spat Comput
Trost Z, Won AS, Boyapati HPN, Costa K, Davenport J, D'Onofrio G, Drager L, Shum PC, Pierce MW, Fraenkel L, Soares Iii W.   +10 more
europepmc   +1 more source

Trends in Use of Medications for Opioid Use Disorder among Commercially Insured U.S. Surgical Patients, 2016 to 2022. [PDF]

Anesthesiology
Bicket MC, Qi X, Buchwalder K, Chua KP, Lagisetty P, Gunaseelan V, Waljee JF, Brummett CM, Li Y, Nguyen T.   +9 more
europepmc   +1 more source

U<b>se of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case serie</b>s. [PDF]

Drug Alcohol Depend Rep
Wong A, Nolan S, Bach P, Janssen RM, De Wolfe TJ, Dickhout P, Beauchesne R, Yang F, Johnson C, Carter A, Nosyk B, Dennis BB.   +11 more
europepmc   +1 more source

Longitudinal Patterns of Dental Health Care Utilization 18 Months Before and 36 Months After Initiation of Index Medications for Opioid Use Disorder. [PDF]

J Addict Med
Roy PJ, Yuan N, Li Y, Butler AM, Nickel KB, Gibson G, Hubbard CC, Boyer TL, Suda KJ, Durkin MJ.   +9 more
europepmc   +1 more source

Using narrative and informational messages to improve correctional professionals' attitudes toward medications for opioid use disorder. [PDF]

Health Justice
Harrell-Webber A, Zhao X, Horoszko UA, Murphy A, Smith L, Taxman FS.   +5 more
europepmc   +1 more source